☰

Jonathan D. Buhrman, Ph.D. - Publications

Affiliations: 
2012 Immunology University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Wei P, Jordan KR, Buhrman JD, Lei J, Deng H, Marrack P, Dai S, Kappler JW, Slansky JE, Yin L. Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34074778 DOI: 10.1073/pnas.2100588118  0.758
2016 Waugh KA, Leach SM, Moore BL, Bruno TC, Buhrman JD, Slansky JE. Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model. Journal of Immunology (Baltimore, Md. : 1950). PMID 27371726 DOI: 10.4049/Jimmunol.1600589  0.752
2013 Buhrman JD, Jordan KR, Munson DJ, Moore BL, Kappler JW, Slansky JE. Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor. The Journal of Biological Chemistry. 288: 33213-25. PMID 24106273 DOI: 10.1074/Jbc.M113.509554  0.821
2013 Buhrman JD, Slansky JE. Mimotope vaccine efficacy gets a "boost" from native tumor antigens. Oncoimmunology. 2: e23492. PMID 23734309 DOI: 10.4161/Onci.23492  0.826
2013 Buhrman JD, Jordan KR, U'ren L, Sprague J, Kemmler CB, Slansky JE. Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens. Cancer Research. 73: 74-85. PMID 23161490 DOI: 10.1158/0008-5472.Can-12-1005  0.641
2013 Buhrman JD, Slansky JE. Improving T cell responses to modified peptides in tumor vaccines. Immunologic Research. 55: 34-47. PMID 22936035 DOI: 10.1007/S12026-012-8348-9  0.847
2013 Slansky JE, Buhrman JD. Abstract B29: Improving the identification of beneficial mimotopes using a representative tumor-specific T cell receptor. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-B29  0.831
2012 Jordan KR, Buhrman JD, Sprague J, Moore BL, Gao D, Kappler JW, Slansky JE. TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines. Cancer Immunology, Immunotherapy : Cii. 61: 1627-38. PMID 22350070 DOI: 10.1007/S00262-012-1217-5  0.801
Show low-probability matches.